back to the latest
February 21, 2026

Plus de 61 % de réduction des arrêts maladie après une seule intervention ?

Suite au déploiement du traitement de surface antimicrobien de Resysten au sein de l'Agence Nationale de l'Énergie, le taux d'absentéisme pour maladie a été réduit de plus de moitié.

Following the implementation of Resysten’s antimicrobial surface treatment at the National Energy Agency, the rate of sick leave dropped by more than half.

The technology is invisible – but the results are impossible to miss:

Dramatic reduction in illness rates

Increased productivity: fewer sick days mean fewer workflow disruptions

Improved availability: fewer illnesses lead to fewer unexpected shutdowns

Stronger employer branding: A responsible, future-oriented, health-conscious employer image boosts employee commitment and loyalty

Date of implementation: July 2023

Evaluation period: July 2023 – May 2025

Reduction achieved: 61.14%

Location: National Energy Agency

Don’t wait any longer! Boost your efficiency while saving costs!

Invest in prevention – it’s a proven return on investment!